Free Float 73,56 %
Shares Float 833,44 M
Shares Outstanding 1,13 B
Brain+ A/S
Share · DK0061670205 (XCSE)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Brain+ A/S
No Price
Share Float & Liquidity
Company Profile for Brain+ A/S Share
Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company develops cognitive stimulation therapy (CST), a therapy that treats the main symptoms of dementia; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, memory test for early detection and monitoring of Alzheimer's. In addition, it develops an interface for clinicians to track and trace the patient's treatment progress. The company was incorporated in 2012 and is based in Copenhagen, Denmark. Brain+ A/S was formerly a subsidiary of Brain+ Holding ApS.
Company Data
Name Brain+ A/S
Company Brain+ A/S
Website
https://www.brain-plus.com
Primary Exchange 
NASDAQ COPENHAGEN A/S
NASDAQ COPENHAGEN A/S
ISIN DK0061670205
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Devika Rani Wood
Country Denmark
Currency DKK
Employees 0,0 T
Address KOebmagergade 53, 1150 Copenhagen
IPO Date 2021-10-07
Stock Splits
| Date | Split |
|---|---|
| 08.05.2023 | 3:2 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ COPENHAGEN A/S | BRAINP.CO |
More Shares
Investors who hold Brain+ A/S also have the following shares in their portfolio:
